JONATHAN T. LORD - 11 Jun 2021 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Jonathan T. Lord
Issuer symbol
BIOL
Transactions as of
11 Jun 2021
Transactions value $
$0
Form type
4
Filing time
14 Jun 2021, 20:50:13 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Stock Appreciation Right Award $0 +189,902 $0.000000 189,902 11 Jun 2021 Common Stock 189,902 $0.8400 Direct F1
transaction BIOL Restricted Stock Unit Award $0 +330,000 $0.000000 330,000 11 Jun 2021 Common Stock 330,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the stock appreciation rights subject to this SAR, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant.
F2 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F3 The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.